-
Kentucky's $42M Ibogaine Budget Plan For Opioid Crisis Hears Testimonies At Second Meeting
Tuesday, September 19, 2023 - 4:40pm | 485Kentucky’s Opioid Abatement Advisory Commission (KYOAAC) held the second of two public hearings and general information sessions regarding its plan to allocate $42 million from state funds for ibogaine research to support the treatment of addictions and to help stem opioid...
-
Diabetes Drug Ozempic May Hold Key to Breaking Addictions: The Guardian
Monday, July 3, 2023 - 3:26am | 483Novo Nordisk A/S (OTC:NONOF) manufactured diabetes and weight loss drug Ozempic, known scientifically as semaglutide, may have the potential to help break addictions, The Guardian reports. Unexpected Changes Users of the drug have reported a decrease in addictive behaviors, such as smoking and...
-
EXCLUSIVE: Next-Generation Psychedelics, MEAI - What And When
Tuesday, January 24, 2023 - 4:32pm | 573(Part three of a four-part series) See previous parts of the series: Next-Generation Psychedelics: The Case Of MEAI And Its Potential To Treat Addiction Next-Generation Psychedelics, MEAI - How And Why, An Israeli Scientist Explains MEAI is a potent synthetic molecule essentially developed in the...
-
Next-Generation Psychedelics: The Case Of MEAI And Its Potential To Treat Addiction
Friday, January 20, 2023 - 10:29am | 563(Part one of a four-part series) Increasing evidence of psychedelics’ potential for benefiting both mental and physical health conditions are moving biotech companies and scientists in the sector to major innovative heights. Psychedelic science is growing in terms of treatment specificity, as...
-
Can Ketamine Treat Alcohol Addiction? In-Clinic Therapy Vs. Retreats
Thursday, October 13, 2022 - 11:25am | 952(Part four of a four-part series - Read part three) The reason why companies offering psychedelic-assisted therapy only use ketamine is that at the moment it is the only one that holds a medical license. While psilocybin and MDMA are showing enormous promise, they are still in ...
-
Can Ketamine Treat Alcohol Addiction? The Awakn Approach
Monday, October 10, 2022 - 10:24am | 893(Part three of a four-part series) As for ketamine-assisted therapy, biotech psychedelics company Awakn Life Sciences (OTC: AWAKNF) offers two distinct protocols. One is called KARE (Ketamine in the Reduction of Alcoholic Relapse) and is specific to alcohol use disorder, while the other, KAP (...
-
Major Psychedelics Firm Is Studying Magic Mushrooms To Treat Meth Addiction
Friday, September 16, 2022 - 3:10pm | 308Life sciences company Revive Therapeutics Ltd. (OTCQB: RVVTF) is advancing its first Phase I/II clinical trial of oral psilocybin for methamphetamine use disorder treatment while also developing an oral psilocybin thin film strip product. Revive is currently studying psilocybin’s potential as...
-
Cannabis As A Tool To Fight Addictions Globally
Wednesday, January 20, 2021 - 11:59am | 738This article by Johnny Green was originally published on Cannabis & Tech Today, and appears here with permission. Various cultures and countries have used cannabis for medical purposes going back thousands of years. The cannabis plant is capable of providing tremendous wellness...